Â¥
39.26
May 31
Business Description
BGI Genomics Co Ltd
ISIN : CNE100003449
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.66 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | 6.56 | |||||
Interest Coverage | 2.95 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.11 | |||||
Beneish M-Score | -2.38 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -20.5 | |||||
3-Year EBITDA Growth Rate | -39.6 | |||||
3-Year EPS without NRI Growth Rate | -64.7 | |||||
3-Year Book Growth Rate | 17.3 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.84 | |||||
9-Day RSI | 37.35 | |||||
14-Day RSI | 40.71 | |||||
6-1 Month Momentum % | -19.84 | |||||
12-1 Month Momentum % | -30.16 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.54 | |||||
Quick Ratio | 2.35 | |||||
Cash Ratio | 1.71 | |||||
Days Inventory | 110.19 | |||||
Days Sales Outstanding | 133.07 | |||||
Days Payable | 147.36 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.55 | |||||
Dividend Payout Ratio | 2.12 | |||||
3-Year Dividend Growth Rate | 114.7 | |||||
Forward Dividend Yield % | 2.55 | |||||
5-Year Yield-on-Cost % | 8.59 | |||||
3-Year Average Share Buyback Ratio | -1.1 | |||||
Shareholder Yield % | -0.44 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 50.85 | |||||
Operating Margin % | 6.27 | |||||
Net Margin % | 1.52 | |||||
FCF Margin % | -18.84 | |||||
ROE % | 0.64 | |||||
ROA % | 0.47 | |||||
ROIC % | 3.02 | |||||
ROC (Joel Greenblatt) % | 5.83 | |||||
ROCE % | 1.66 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 237.94 | |||||
PE Ratio without NRI | 83.35 | |||||
Shiller PE Ratio | 24.39 | |||||
PEG Ratio | 11.26 | |||||
PS Ratio | 3.84 | |||||
PB Ratio | 1.64 | |||||
Price-to-Tangible-Book | 1.75 | |||||
Price-to-Operating-Cash-Flow | 50.73 | |||||
EV-to-EBIT | 69.72 | |||||
EV-to-EBITDA | 69.72 | |||||
EV-to-Revenue | 2.85 | |||||
EV-to-FCF | -15.23 | |||||
Price-to-Projected-FCF | 1.32 | |||||
Price-to-Graham-Number | 2.55 | |||||
Price-to-Net-Current-Asset-Value | 3.79 | |||||
Price-to-Net-Cash | 9.53 | |||||
Earnings Yield (Greenblatt) % | 1.43 | |||||
FCF Yield % | -4.89 | |||||
Forward Rate of Return (Yacktman) % | -8.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BGI Genomics Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 4,216 | ||
EPS (TTM) (Â¥) | 0.165 | ||
Beta | 1.27 | ||
Volatility % | 33.26 | ||
14-Day RSI | 40.71 | ||
14-Day ATR (Â¥) | 0.998666 | ||
20-Day SMA (Â¥) | 40.7995 | ||
12-1 Month Momentum % | -30.16 | ||
52-Week Range (Â¥) | 33 - 62.97 | ||
Shares Outstanding (Mil) | 413.91 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BGI Genomics Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BGI Genomics Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
BGI Genomics Co Ltd Frequently Asked Questions
What is BGI Genomics Co Ltd(SZSE:300676)'s stock price today?
When is next earnings date of BGI Genomics Co Ltd(SZSE:300676)?
Does BGI Genomics Co Ltd(SZSE:300676) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |